← Open Payments lookup

MARIA PILAR FAYLONA: Open Payments

NPI 1770677676 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,189 in 62 payments from 16 companies in 2025. Trend: 2023 $1,366 · 2024 $1,227 · 2025 $1,189

Food & beverage: $1,189
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$274
Bayer Healthcare Pharmaceuticals Inc.12$160
Novo Nordisk Inc10$153
Lilly USA, LLC5$112
GlaxoSmithKline, LLC.5$106
Boehringer Ingelheim Pharmaceuticals, Inc.3$74
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$69
PFIZER INC.3$62
SHIELD THERAPEUTICS INC2$40
Kowa Pharmaceuticals America, Inc.1$24

Products named: Kerendia, FARXIGA, JARDIANCE, Ozempic, AIRSUPRA, SHINGRIX, MOUNJARO, XIFAXAN.

Industry payments across NV — which companies pay providers there.